These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12452208)

  • 1. Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment.
    Aldridge RE; Hancox RJ; Cowant JO; Frampton CM; Town GI; Taylor DR
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):492-7. PubMed ID: 12452208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
    Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
    Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence oc glycocorticoid therapy on sputum ECP concentration in symptomatic patients with bronchial asthma].
    Hermanowicz-Salamon J; Grubek-Jaworska H; Wrońska J; Droszcz W; Chazan R
    Pneumonol Alergol Pol; 2002; 70(11-12):527-35. PubMed ID: 12884561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
    Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
    Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma.
    van Dalen CJ; Aldridge RE; Chan T; Senthilmohan R; Hancox RJ; Cowan JO; Taylor DR; Town GI; Kettle AJ
    Ann Allergy Asthma Immunol; 2009 Oct; 103(4):348-53. PubMed ID: 19852201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide down-regulates eosinophil locomotion but has no effects on ECP release or on H2O2 production.
    Lantero S; Oddera S; Silvestri M; Gonzalez Rodriguez R; Morelli MC; Rossi GA
    Lung; 1999; 177(4):219-28. PubMed ID: 10384060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline.
    Adelroth E; Rosenhall L; Johansson SA; Linden M; Venge P
    Am Rev Respir Dis; 1990 Jul; 142(1):91-9. PubMed ID: 2195937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma.
    Park JW; Whang YW; Kim CW; Park YB; Hong CS
    Allergy Asthma Proc; 1998; 19(2):61-7. PubMed ID: 9578913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients.
    Bacci E; Cianchetti S; Ruocco L; Bartoli ML; Carnevali S; Dente FL; Di Franco A; Giannini D; Macchioni P; Vagaggini B; Morelli MC; Paggiaro PL
    Clin Exp Allergy; 1998 Oct; 28(10):1237-43. PubMed ID: 9824390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do sputum eosinophils and ECP relate to the severity of asthma?
    Ronchi MC; Piragino C; Rosi E; Stendardi L; Tanini A; Galli G; Duranti R; Scano G
    Eur Respir J; 1997 Aug; 10(8):1809-13. PubMed ID: 9272923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood.
    Prehn A; Seger RA; Torresani T; Molinari L; Sennhauser FH
    Pediatr Allergy Immunol; 2000 May; 11(2):87-94. PubMed ID: 10893010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD).
    Gibson PG; Woolley KL; Carty K; Murree-Allen K; Saltos N
    Clin Exp Allergy; 1998 Sep; 28(9):1081-8. PubMed ID: 9761011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing.
    Alvarez MJ; Olaguibel JM; García BE; Rodríquez A; Tabar AI; Urbiola E
    Allergy; 2000 Apr; 55(4):355-62. PubMed ID: 10782520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood.
    Pizzichini E; Pizzichini MM; Efthimiadis A; Dolovich J; Hargreave FE
    J Allergy Clin Immunol; 1997 Apr; 99(4):539-44. PubMed ID: 9111500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.
    Salome CM; Reddel HK; Ware SI; Roberts AM; Jenkins CR; Marks GB; Woolcock AJ
    Am J Respir Crit Care Med; 2002 Jan; 165(1):15-21. PubMed ID: 11779724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
    Belda J; Giner J; Casan P; Sanchis J
    Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
    Venge P; Dahl R; Peterson CG
    Int Arch Allergy Appl Immunol; 1988; 87(3):306-12. PubMed ID: 3144513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.